Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
234 | 19638 | 46.5 | 85% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
32 | 105649 | VIROLOGY//AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1 |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
1839 | 2393 | HIV 1 INTEGRASE//INTEGRASE//RALTEGRAVIR |
2388 | 2193 | PERSISTENT VIRAL DIS//FRIEND VIRUS//MOMULV TS1 |
2663 | 2107 | RETROVIRAL VECTORS//RETROVIRAL VECTOR//SELECTIVE AMPLIFIER GENE |
3571 | 1879 | VIRUS CELL INTERACT SECT//GAG//M PMV |
3733 | 1844 | LENTIVIRAL VECTOR//LENTIVIRAL VECTORS//EXPT HEMATOL |
3893 | 1813 | TAT//TAT PROTEIN//TAR RNA |
5100 | 1605 | RNA DIMERIZATION//NCP7//HIV 1 NUCLEOCAPSID PROTEIN |
9585 | 1074 | TRIM5 ALPHA//TRIMCYP//TRIM5 |
9619 | 1070 | APOBEC3G//VIF//APOBEC3F |
12324 | 850 | REV//RRE//REV PROTEIN |
12548 | 835 | VPR//VPX//HIV 1 VPR |
15128 | 660 | GENE THER Y S//PATHOTROPIC TARGETING//RETROVIRAL ENTRY |
16643 | 578 | FOAMY VIRUS//SPUMARETROVIRUS//ABT RETROVIRALE GENEXP S |
17670 | 524 | VPU//BST 2//TETHERIN |
26254 | 213 | XMRV//XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS//XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS XMRV |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | APOBEC3G | Author keyword | 304 | 92% | 1% | 122 |
2 | INTEGRASE | Author keyword | 283 | 58% | 2% | 322 |
3 | HIV 1 INTEGRASE | Author keyword | 271 | 83% | 1% | 151 |
4 | VIF | Author keyword | 219 | 82% | 1% | 129 |
5 | VPR | Author keyword | 204 | 74% | 1% | 152 |
6 | TRIM5 ALPHA | Author keyword | 202 | 97% | 0% | 59 |
7 | RETROVIRUS | Author keyword | 185 | 29% | 3% | 549 |
8 | HIV 1 | Author keyword | 175 | 14% | 6% | 1129 |
9 | HIV DRUG ISTANCE PROGRAM | Address | 165 | 46% | 1% | 265 |
10 | RETROVIROLOGY | Journal | 158 | 34% | 2% | 377 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | APOBEC3G | 304 | 92% | 1% | 122 | Search APOBEC3G | Search APOBEC3G |
2 | INTEGRASE | 283 | 58% | 2% | 322 | Search INTEGRASE | Search INTEGRASE |
3 | HIV 1 INTEGRASE | 271 | 83% | 1% | 151 | Search HIV+1+INTEGRASE | Search HIV+1+INTEGRASE |
4 | VIF | 219 | 82% | 1% | 129 | Search VIF | Search VIF |
5 | VPR | 204 | 74% | 1% | 152 | Search VPR | Search VPR |
6 | TRIM5 ALPHA | 202 | 97% | 0% | 59 | Search TRIM5+ALPHA | Search TRIM5+ALPHA |
7 | RETROVIRUS | 185 | 29% | 3% | 549 | Search RETROVIRUS | Search RETROVIRUS |
8 | HIV 1 | 175 | 14% | 6% | 1129 | Search HIV+1 | Search HIV+1 |
9 | VPU | 152 | 80% | 0% | 95 | Search VPU | Search VPU |
10 | RALTEGRAVIR | 126 | 55% | 1% | 159 | Search RALTEGRAVIR | Search RALTEGRAVIR |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MURINE LEUKEMIA VIRUS | 1276 | 55% | 8% | 1609 |
2 | ENZYME APOBEC3G | 475 | 90% | 1% | 204 |
3 | NONDIVIDING CELLS | 466 | 64% | 2% | 461 |
4 | TYPE 1 INTEGRASE | 454 | 88% | 1% | 216 |
5 | HUMAN SPUMARETROVIRUS | 433 | 96% | 1% | 131 |
6 | PREINTEGRATION COMPLEXES | 413 | 87% | 1% | 206 |
7 | VIF PROTEIN | 410 | 81% | 1% | 247 |
8 | STRAND TRANSFER | 351 | 61% | 2% | 375 |
9 | IMMUNODEFICIENCY VIRUS TYPE 1 | 320 | 14% | 11% | 2076 |
10 | LONG TERMINAL REPEAT | 315 | 27% | 5% | 1005 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RETROVIROLOGY | 158 | 34% | 2% | 377 |
2 | HUMAN GENE THERAPY | 84 | 16% | 3% | 496 |
3 | HUMAN GENE THERAPY METHODS | 5 | 19% | 0% | 24 |
4 | JOURNAL OF HUMAN VIROLOGY | 1 | 10% | 0% | 10 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates | 2012 | 190 | 46 | 59% |
Multiple APOBEC3 Restriction Factors for HIV-1 and One Vif to Rule Them All | 2014 | 26 | 267 | 84% |
Gene therapy clinical trials worldwide to 2012 an update | 2013 | 133 | 60 | 47% |
The Restriction Factors of Human Immunodeficiency Virus | 2012 | 66 | 96 | 97% |
HIV-1 accessory proteins - Ensuring viral survival in a hostile environment | 2008 | 279 | 101 | 74% |
The structural biology of HIV assembly | 2008 | 210 | 140 | 94% |
Intrinsic host restrictions to HIV-1 and mechanisms of viral escape | 2015 | 2 | 114 | 95% |
Host factors for retroviral integration site selection | 2015 | 2 | 78 | 94% |
The APOBEC3 cytidine deaminases: An innate defensive network opposing exogenous retroviruses and endogenous retroelements | 2008 | 209 | 160 | 83% |
APOBECs and virus restriction | 2015 | 2 | 226 | 84% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HIV DRUG ISTANCE PROGRAM | 165 | 46% | 1.3% | 265 |
2 | VIRAL BIOCHEM SECT | 92 | 92% | 0.2% | 36 |
3 | MCGILL AIDS | 67 | 52% | 0.5% | 92 |
4 | VIRUS CELL INTERACT SECT | 67 | 72% | 0.3% | 52 |
5 | VIRAL RECOMBINAT SECT | 53 | 95% | 0.1% | 18 |
6 | ORETRO | 32 | 60% | 0.2% | 35 |
7 | ABT RETROVIRALE GENEXP S | 31 | 92% | 0.1% | 12 |
8 | MOL VIROL GENE THER Y | 31 | 45% | 0.3% | 51 |
9 | AIDS VACCINE PROGRAM | 30 | 31% | 0.4% | 82 |
10 | VIRAL MUTAT SECT | 29 | 71% | 0.1% | 24 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000015113 | HIV 1 PROTEASE//HIV PROTEASE//KNI 272 |
2 | 0.0000014842 | FELINE IMMUNODEFICIENCY VIRUS//CAPRINE ARTHRITIS ENCEPHALITIS VIRUS//FIV |
3 | 0.0000013684 | AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1//AIDS |
4 | 0.0000010449 | HUMAN ENDOGENOUS RETROVIRUS//ADAR//ENDOGENOUS RETROVIRUS |
5 | 0.0000007219 | MARINER//SLEEPING BEAUTY//TRANSGENIC CHICKEN |
6 | 0.0000006843 | GENE DELIVERY//GENE THERAPY//POLYETHYLENIMINE |
7 | 0.0000006569 | HTLV I//HTLV 1//HAM TSP |
8 | 0.0000006062 | CAS9//GENOME EDITING//CRISPR |
9 | 0.0000005628 | ONCOLYTIC VIRUS//VIROTHERAPY//CYTOSINE DEAMINASE |
10 | 0.0000005344 | CELL PENETRATING PEPTIDE//CELL PENETRATING PEPTIDES//PROTEIN TRANSDUCTION DOMAINS |